Chloral hydrate shouldn’t be banned - just used cautiously Newsletter Article 15 February 2013 Pages: 2 - 2
Greater understanding, greater safety of antiarrhythmics Newsletter Article 15 February 2013 Pages: 4 - 4
More investigation of H. influenzae vaccination needed Newsletter Article 15 February 2013 Pages: 5 - 5
Drug design by virtual reality - how close are we? Ian Mundell Newsletter Article 15 February 2013 Pages: 7 - 7
Adjuvant therapy beneficial and cost-effective for early breast cancer Newsletter Article 15 February 2013 Pages: 8 - 8
South African tree yields potent microtubule inhibitor Gill Higgins Newsletter Article 15 February 2013 Pages: 11 - 11
Vaccination produces promising T cell responses in MS Newsletter Article 15 February 2013 Pages: 12 - 12
Etoposide-carboplatin combination shows promise in gastric cancer Newsletter Article 15 February 2013 Pages: 13 - 13
Very low-dose zidovudine shows antiretroviral activity Newsletter Article 15 February 2013 Pages: 14 - 14
Aspergillosis deaths reduced with itraconazole/amphotericin B Newsletter Article 15 February 2013 Pages: 15 - 15
Doxorubicin dosage confirmed important for osteosarcoma prognosis Newsletter Article 15 February 2013 Pages: 15 - 15
Safe haem preparation allows early treatment of acute porphyria Newsletter Article 15 February 2013 Pages: 16 - 16
Encouraging comparative results with SKB’s new NSAID nabumetone Newsletter Article 15 February 2013 Pages: 17 - 17
Terbutaline effective for infants with acute wheezing Newsletter Article 15 February 2013 Pages: 18 - 18
Concurrent therapy with lovastatin and antihypertensives is safe Newsletter Article 15 February 2013 Pages: 18 - 18